Wednesday’s analyst upgrades and downgrades

Analysts broadly trimmed price targets after mixed first-quarter results and cautious near-term guidance, but several still reiterated Buy/Outperform calls on names such as Shopify, Ero Copper, Nutrien, Colliers, Cameco and TMX. Shopify fell more than 15% on softer Q2 outlook despite 34% sales growth and 35% GMV growth, while Ero Copper and Nutrien drew upgrades on improving cash flow and pricing tailwinds. IA Financial was downgraded on valuation and earnings quality, while several other Canadian names saw mostly modest target changes tied to earnings beats, guidance, or valuation.

Analysis

The common thread is not “beats and misses,” but dispersion in operating leverage. The market is rewarding businesses where growth is still translating into incremental margin or cash conversion, and punishing names where management is leaning on back-half normalization or accounting optics to defend guidance. That makes the next leg more about estimate revisions than headline quarter quality: names with improving balance sheet flexibility and visible pricing power should keep outperforming even if the macro softens.

Shopify looks like a classic post-print de-rate that can reverse quickly if gross profit growth re-accelerates into the next quarter. The bigger second-order read is that merchant solutions take-rate expansion can keep compounding even if top-line growth normalizes, which means the stock may be more sensitive to payment penetration metrics than revenue itself. The risk is that investor patience is low after a large drawdown; any sign of opex creep will keep the multiple compressed despite strong GMV trends.

The strongest relative setup is in commodity-linked balance-sheet repair stories. Ero and Nutrien both benefit from the market shifting from “what were the quarterly numbers?” to “how much free cash flow is embedded in the next 2-3 quarters?” Ero’s leverage path matters more than guidance nudges; Nutrien’s re-rating depends on whether fertilizer prices stay elevated long enough for consensus to lift H2/26 and 2027 EBITDA, not just Q2.

On the laggards, IA Financial and Colliers share a similar issue: good businesses, but the market is no longer paying for mixed-quality beats or backend-loaded execution. IA’s underappreciated risk is that wealth momentum can mask softer insurance economics, while Colliers faces a slower path from revenue to earnings because margin investment is front-loaded. The consensus may be underestimating how long investors will tolerate these optics before demanding cleaner, more immediate EPS conversion.

Key Decisions for Investors

• Buy SHOP on weakness over the next 1-3 weeks, but size it as a tactical trade: target a 10-15% rebound if next-quarter commentary confirms payments penetration gains; cut if opex re-accelerates or North America GMV decelerates.
• Stay long ERO into the next 1-2 quarters; the setup favors a re-rate as leverage falls and FCF turns visibly positive. Risk/reward improves on any pullback toward peer multiples, with downside limited by balance-sheet support.
• Add NTR on a 3-6 month horizon as a fertilizer-price lag trade. The trade works if pricing holds into H2/26 and consensus revisions broaden beyond the next quarter; trim if crop price strength fades before volume recovery arrives.
• Underweight or short-rally IAFNF versus large-cap insurers over the next 1-2 months. The thesis is that lower-quality earnings and higher sensitivity to market-related items will keep a valuation discount in place despite solid capital returns.
• Use CIGI as a patient long only on further weakness, not strength. The stock is attractive on longer-duration cash flow, but the next catalyst requires proof that margin investment starts converting into AEBITDA, likely a 2-3 quarter story.